May 4 (Reuters) - Australia's medical centre operator Healius (HLS) on Thursday recommended that its shareholders reject the A$1.52 billion ($1.01 billion) all-share takeover offer by Australian Clinical Labs (ACL) .
The offer, made in March, has "no cash and no premium" and is "plainly inadequate", Healius said in its statement.
($1 = 1.5047 Australian dollars)
News: HLS Australia's Healius rejects $1 bln buyout offer by Australian Clinical Labs
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
79.5¢ |
Change
-0.020(2.45%) |
Mkt cap ! $588.1M | |||
| Open | High | Low | Value | Volume |
| 81.0¢ | 82.5¢ | 79.0¢ | $1.599M | 1.982M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 57775 | 79.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 79.5¢ | 51183 | 29 |
View Market Depth
| Last trade - 11.19am 13/08/2025 (20 minute delay) ? |
| HLS (ASX) Chart |